A blood test could help determine who benefits from checkpoint inhibitors in lung cancer, and the FDA approves a drug combination for certain patients with acute myeloid leukemia.

by Marci A. Landsmann

Esophageal cancer increases in the middle-aged, and adolescent and young adult leukemia survivors face continued mortality risk after treatment ends.

by Eric Fitzsimmons

First child to receive CAR T-cell therapy celebrates 10 years cancer-free, and authorization denials delay treatment for patients with Medicare Advantage.

by Marci A. Landsmann

Adolescents and young adult cancer survivors at higher risk for dying from a new cancer diagnosis, and FDA grants full approval to Enhertu for metastatic HER2-postive breast cancer.

by Eric Fitzsimmons

FDA proposes ban on menthol cigarettes, and proton beam therapy on the rise but with growing racial disparity.

by Thomas Celona

Study finds a connection between bacteria and fast-growing prostate cancer, and researchers measure underrepresentation of Black patients in clinical trials.

by Kevin McLaughlin

Experts discuss shortcomings of current COVID-19 vaccines in people with cancer while highlighting possibilities of T-cell activation.

by Thomas Celona

CAR T-cell therapy approved for relapsed large B-cell lymphoma, and screening catches lung cancer earlier, although disparities persist.

by Kevin McLaughlin

Chemo brain may provide clues for long-haul COVID-19, and researchers analyze relationship between obesity and cancer.

by Marci A. Landsmann

FDA approves combination immunotherapy for treating melanoma, and screening tool improves pancreatic cancer detection.

by Kevin McLaughlin